AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-11.52%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.31B
AUM Growth
+$3.31B
(+160%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
59.15%
Top 10 Holdings %
Top 10 Hldgs %
93.67%
Holding
72
New
7
Increased
11
Reduced
6
Closed
11
Top Buys
| 1 |
BUFF
Blue Buffalo Pet Products, Inc
BUFF
|
$2.06B |
| 2 |
Yum! Brands
YUM
|
$12M |
| 3 |
BLUE
bluebird bio
BLUE
|
$9.84M |
| 4 |
Morgan Stanley
MS
|
$7.88M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$4.59M |
Top Sells
| 1 |
Amazon
AMZN
|
$28.2M |
| 2 |
MBLY
Mobileye N.V.
MBLY
|
$26.6M |
| 3 |
AerCap
AER
|
$17.2M |
| 4 |
American Airlines Group
AAL
|
$16M |
| 5 |
Alibaba
BABA
|
$11.8M |
Sector Composition
| 1 | Consumer Staples | 62.23% |
| 2 | Healthcare | 26.66% |
| 3 | Consumer Discretionary | 7.05% |
| 4 | Financials | 2.04% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BUFF
1
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $2.06B | 46.01% | +114,987,547 | New | +$2.06B |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $618M | 13.8% | 57,517,978 | – | – |
|
|
WW
3
DELISTED
WW International
WW
| $188M | 4.2% | 29,443,300 | – | – |
|
4
Incyte
INCY
$16.5B
| $54.1M | 1.21% | 490,000 +10,000 | +2% | +$1.1M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $46.3M | 1.04% | 440,000 +5,000 | +1% | +$527K |
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $35M | 0.78% | 435,000 -20,000 | -4% | -$1.61M |
|
7
Mastercard
MA
$538B
| $27M | 0.6% | 300,000 -100,000 | -25% | -$9.01M |
|
|
BLUE
8
DELISTED
bluebird bio
BLUE
| $26.9M | 0.6% | 315,000 +115,000 | +58% | +$9.84M |
|
|
LNKD
9
DELISTED
LinkedIn Corporation
LNKD
| $23.8M | 0.53% | 125,000 -6,500 | -5% | -$1.24M |
|
|
KITE
10
DELISTED
Kite Pharma, Inc.
KITE
| $21.7M | 0.49% | 390,000 -35,000 | -8% | -$1.95M |
|
11
Nektar Therapeutics
NKTR
$568M
| $19.7M | 0.44% | 1,800,000 +100,000 | +6% | +$1.1M |
|
|
12
Alibaba
BABA
$322B
| $17.7M | 0.4% | 300,000 -200,000 | -40% | -$11.8M |
|
|
ARRY
13
DELISTED
Array Biopharma Inc
ARRY
| $16.9M | 0.38% | 3,710,000 | – | – |
|
14
Ionis Pharmaceuticals
IONS
$6.79B
| $16.2M | 0.36% | 400,000 | – | – |
|
|
15
Agios Pharmaceuticals
AGIO
$2.19B
| $15.9M | 0.35% | 225,000 +65,000 | +41% | +$4.59M |
|
16
Bank of America
BAC
$376B
| $15.6M | 0.35% | 1,000,000 | – | – |
|
17
LendingClub
LC
$1.97B
| $15.5M | 0.35% | 1,175,000 +100,000 | +9% | +$1.32M |
|
18
General Motors
GM
$55.8B
| $13.5M | 0.3% | 450,000 | – | – |
|
|
19
Yum! Brands
YUM
$40.8B
| $12M | 0.27% | +150,000 | New | +$12M |
|
|
JUNO
20
DELISTED
Juno Therapeutics, Inc.
JUNO
| $9.56M | 0.21% | 235,000 +45,000 | +24% | +$1.83M |
|
|
21
Morgan Stanley
MS
$240B
| $7.88M | 0.18% | +250,000 | New | +$7.88M |
|
22
Seres Therapeutics
MCRB
$166M
| $5.93M | 0.13% | 200,000 +39,943 | +25% | +$1.18M |
|
|
CCXI
23
DELISTED
ChemoCentryx, Inc.
CCXI
| $5.45M | 0.12% | 900,000 | – | – |
|
|
JMEI
24
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $4.94M | 0.11% | 500,000 | – | – |
|
|
RXDX
25
DELISTED
Ignyta, Inc.
RXDX
| $4.17M | 0.09% | 475,000 +25,000 | +6% | +$220K |
|